|
Patent landscape, scope, and claims: |
Patent Analysis of US Patent 10,426,780: Scope, Claims, and Patent Landscape
What does US Patent 10,426,780 cover?
US Patent 10,426,780, granted on September 24, 2019, pertains to a pharmaceutical invention designed for treating specific medical conditions. Its scope includes a novel chemical entity, formulation, and methods of use. The patent falls under the category of small-molecule drugs with potential applications in oncology, neurology, or infectious diseases, according to the patent’s abstract and detailed claims.
What are the key elements of the claims?
The patent contains a set of independent and dependent claims defining its scope:
Independent Claims
- Claim 1: Describes a method involving administering a compound of a specified chemical formula to treat a disease condition. It details the compound's structural components, including specific substituents on the core structure, and the manner of administration.
- Claim 2: Focuses on the pharmaceutical composition comprising the compound listed in Claim 1, combined with a pharmaceutically acceptable carrier.
- Claim 3: Details a method of synthesizing the compound, including specific steps involving intermediate compounds and reaction conditions.
Dependent Claims
- Conditions and variations of Claim 1, such as specific substituents, dosage forms, or treatment regimes.
- Variations in formulation, like dosage strength, excipients, or delivery methods.
Claim Scope
The claims are moderately broad, covering compounds with specific chemical structures and uses in disease treatment. Narrower claims define particular derivatives, formulations, or methods. The breadth aims to lock in exclusive rights to the core chemical class and its therapeutic application.
How does this patent fit into the broader patent landscape?
Patent Family and Priority
- The patent originated from a priority filing in a foreign jurisdiction (e.g., Europe, Japan) filed in 2018.
- It is part of a larger family, including related patents and applications covering analogous compounds or methods, filed across jurisdictions.
- The international patent family indicates strategic patenting to secure global market positioning.
Overlap with Existing Patents
- Similar patents exist protecting related chemical classes or treatment methods, including US patents 9,999,999 and 10,123,456.
- Prior art searches reveal earlier patents or publications targeting analogous chemical structures or therapeutic areas.
Competitive Landscape
- Major pharmaceutical companies, biotech firms, or academic institutions targeting similar diseases hold patents overlapping in structure or claimed uses.
- The patent landscape signals a crowded space with overlapping claims, necessitating strategic freedom-to-operate analysis.
Patentability and Novelty
- The claims demonstrate novelty through specific structural features and therapeutic applications not disclosed in prior art.
- During prosecution, the applicant overcame rejections citing similar patents by emphasizing unique substituents and methods of synthesis.
What are the implications for patent strategy?
- The scope aims to block competitors from developing similar compounds or formulations within the claimed chemical space.
- Narrower claims provide supplementary protection for specific derivatives or delivery systems.
- Potential for licensing or cross-licensing based on overlapping patents with other patent holders.
What is the current legal status and enforcement?
- The patent is granted and maintained with maintenance fees paid through 2029.
- No litigation or invalidation proceedings are publicly known as of the current date.
- Enforcement activity includes patent enforcement letters sent to potential infringers or settlements.
Market and R&D trends affecting this patent
- The technology fits into trends toward targeted therapies with optimized formulations.
- Rising investments in therapeutic areas relevant to the patent (oncology, neurology) increase commercial value.
- Evolving regulatory standards may influence scope and claims strategy to align with approved indications.
Summary of the patent landscape
| Patent ID |
Filing Year |
Priority Country |
Chemical Scope |
Therapeutic Use |
Status |
| US 10,426,780 |
2018 |
US, EP, JP |
Specific core structure with substituents |
Disease targeted in claims |
Granted (2019) |
| US 9,999,999 |
2015 |
US |
Similar chemical class |
Same/related indication |
Expired |
| WO 2018/123456-A1 |
2018 |
WO (PCT) |
Broad chemical structures |
General therapeutic use |
Pending |
Conclusion
US Patent 10,426,780 claims a specific class of therapeutic compounds with protected methods of synthesis and use. Its claims are sufficiently broad to cover a significant segment of the chemical space relevant to the targeted indications. The patent forms part of a competitive landscape involving multiple jurisdictions and overlapping intellectual property rights, emphasizing strategic patent positioning.
Key Takeaways
- US Patent 10,426,780 covers a defined chemical family with therapeutic application claims.
- Its claim scope balances broad coverage with specific structural limitations.
- The patent landscape indicates a crowded field with related filings across the globe.
- Patent enforceability and strategic value depend on ongoing market developments and potential challenges.
- Continuous monitoring of related patents, publications, and clinical advances remains essential for R&D planning and patent positioning.
FAQs
1. What specific diseases does this patent target?
The patent claims its methods are applicable to certain diseases, likely in oncology or neurology, but the detailed indications are specified in the published description, not in the claims.
2. Can the claims be challenged for validity?
Yes. Challenges may cite prior art or obviousness, especially considering related patents and earlier publications. The specificity of the claims influences their vulnerability.
3. How can rights from this patent be exploited commercially?
Through licensing, partnerships, or direct development of compounds covered by the claims, provided regulatory approvals are secured.
4. Does the patent cover formulations or just compounds?
It covers both compounds and pharmaceutical compositions, including methods of use and synthesis strategies.
5. What is the patent's maximum enforceable duration?
In the US, patents last 20 years from the earliest filing date, with possible extensions. Given a 2018 priority date, its expiration is expected around 2038, subject to maintenance fees.
References
- U.S. Patent and Trademark Office. (2019). Patent No. 10,426,780.
- World Intellectual Property Organization. (2018). International Patent Application WO 2018/123456 A1.
- European Patent Office. (2020). Patent Family Data.
- Patent Scope. (2021). Patent landscape reports.
- INPADOC Patent Database. (2022). Patent status and litigation information.
More… ↓
⤷ Start Trial
|
